The combination of a peginterferon plus ribavirin appears to be as effective in the 'real world' as in randomised, controlled trials

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1641, 2008-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon alfa-2b and ribavirin combination therapy for chronic hepatitis C

By Yeh Frank   Gordon Fredric D  

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 553-563

Future Medicine

Access to resources Recommend Favorite

Peginterferon -2b + ribavirin effective in HCV genotypes 1 and 4

By  

Inpharma, Vol. 1, Iss. 1465, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Arguedas M.  

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 477-479

Adis International

Access to resources Recommend Favorite

Cyclophosphamide plus rituximab appears effective in refractory thrombotic thrombocytopenic purpura

By  

Inpharma, Vol. 1, Iss. 1378, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite